How Common Miscarriage Really Is
If you have experienced a miscarriage, the first thing you need to know — truly absorb, not just read — is that you are not alone, and this was almost certainly not your fault. Miscarriage is one of the most common events in human reproduction, yet it remains one of the least discussed. The silence surrounding pregnancy loss creates an isolation that compounds the grief, leaving many people to wonder whether something is fundamentally wrong with their body.
The numbers tell a different story. According to the American College of Obstetricians and Gynecologists (ACOG), approximately 10–20% of clinically recognized pregnancies end in miscarriage. When very early losses are included — those that occur before a missed period and are often experienced as a late, heavy period — the actual rate may be as high as 30–50% of all conceptions. The vast majority of these losses occur in the first trimester and are caused by chromosomal abnormalities in the embryo that arise randomly during cell division. They are not caused by stress, exercise, intercourse, or anything the pregnant person did or failed to do.
A landmark series published by The Lancet in 2021 called for miscarriage to be recognized as a significant life event deserving of medical attention, emotional support, and follow-up care. The series challenged the long-standing clinical attitude of treating miscarriage as a routine event that does not warrant investigation until it has happened multiple times. While medical practice is slowly shifting in response, many people who have experienced a single loss still feel dismissed by their providers. You deserve better than that, and understanding the medical landscape empowers you to advocate for the care you need.
For those who conceived through at-home insemination, a miscarriage can carry an additional layer of grief. You may have invested significant time, money, and emotional energy into achieving pregnancy through ICI. You may worry that the insemination process itself somehow contributed to the loss. It did not. The method of conception — whether through intercourse, ICI, IUI, or IVF — does not influence miscarriage rates. The same chromosomal lottery that governs natural conception governs assisted conception.
Medical Timeline for Trying Again
The traditional advice to wait three months (or three cycles) before trying again after a miscarriage was based on convention rather than evidence. More recent research has substantially changed this recommendation.
A large study published in The BMJ involving over 30,000 women found that those who conceived within six months of a miscarriage had lower rates of subsequent miscarriage, ectopic pregnancy, and preterm birth compared to those who waited longer than six months. This finding has been replicated in several subsequent studies and has led ACOG and the World Health Organization to revise their guidance. The current evidence-based consensus is that there is no medical reason to delay conception after an uncomplicated first-trimester miscarriage beyond the time needed for one normal menstrual cycle.
Why wait for one cycle? The primary reason is practical, not medical. Having one complete menstrual cycle after a miscarriage establishes a baseline that makes it easier to date a subsequent pregnancy accurately. If you conceive before having a period, it can be difficult to determine gestational age from the last menstrual period, which is the standard dating method. Ultrasound dating can compensate, but having a known last period simplifies care.
There are specific situations where a longer waiting period is medically appropriate:
After a D&C (dilation and curettage): If you had a surgical procedure to manage the miscarriage, your provider may recommend waiting one to two cycles to allow the uterine lining to fully regenerate. This is a reasonable precaution, though evidence on whether D&C affects subsequent implantation timing is mixed.
After methotrexate treatment: If your miscarriage was managed with methotrexate (used in ectopic pregnancies or certain molar pregnancies), you must wait at least three months. Methotrexate is a folate antagonist that can cause birth defects if residual levels are present at conception.
After a second-trimester loss: Losses after 12 weeks may involve more significant physical recovery and warrant a longer waiting period, typically two to three months, depending on the circumstances.
After a molar pregnancy: Your provider will monitor your hCG levels and typically recommend waiting six months to one year, depending on the type of molar pregnancy, before attempting conception again.
For the majority of ICI users who have experienced an early first-trimester loss with spontaneous completion and confirmed return of hCG to zero, resuming insemination after one normal menstrual cycle is both safe and supported by current evidence.
Recurrent Loss Workup: When Testing Is Warranted
The medical definition of recurrent pregnancy loss (RPL) is two or more clinical pregnancy losses, according to ACOG’s updated 2024 Practice Bulletin. Previously, the threshold was three consecutive losses, but the revision reflects growing recognition that investigation after two losses can identify treatable causes earlier.
A standard recurrent loss workup typically includes the following evaluations:
Karyotype analysis of both partners to identify balanced translocations or other chromosomal rearrangements that increase the risk of embryonic chromosomal abnormalities. Balanced translocations are found in approximately 3–5% of couples with recurrent loss.
Uterine anatomy assessment via saline infusion sonogram (SIS) or hysteroscopy to identify structural abnormalities such as a septate uterus, submucosal fibroids, or uterine adhesions (Asherman syndrome). Anatomical factors are found in approximately 10–15% of RPL cases and are often correctable with minimally invasive surgery.
Antiphospholipid antibody testing to screen for antiphospholipid syndrome (APS), an autoimmune condition that increases blood clotting and is associated with recurrent miscarriage. APS is found in approximately 5–15% of women with RPL and is treatable with low-dose aspirin and heparin during pregnancy.
Thyroid function and prolactin testing to identify thyroid disorders (both hypothyroidism and hyperthyroidism) and hyperprolactinemia, which are associated with increased miscarriage risk and are treatable with medication.
Hormonal assessment including day-3 FSH, estradiol, and AMH to evaluate ovarian reserve, as well as luteal-phase progesterone to assess whether progesterone production is sufficient to support early pregnancy.
If you have had a single miscarriage, a full RPL workup is generally not indicated. However, requesting a basic panel — thyroid function, progesterone level in the luteal phase, and vitamin D — is reasonable and can identify easily correctable factors that improve your odds in subsequent cycles. Any provider who dismisses your concerns after a loss should be replaced with one who listens.
Progesterone Support for ICI Cycles
Progesterone is the hormone responsible for maintaining the uterine lining after ovulation and during early pregnancy. A deficiency in progesterone production — sometimes called luteal phase deficiency — has been theorized to contribute to both implantation failure and early miscarriage. The role of progesterone supplementation in preventing miscarriage has been one of the most studied and debated topics in reproductive medicine.
The PRISM trial, a large randomized controlled trial published in the New England Journal of Medicine, found that vaginal progesterone supplementation in early pregnancy did not significantly reduce miscarriage rates in the overall study population. However, a prespecified subgroup analysis revealed a statistically significant benefit for women who had experienced one or more prior miscarriages and who presented with early pregnancy bleeding. For this subgroup, progesterone supplementation increased the live birth rate by approximately 5 percentage points.
For ICI users specifically, progesterone supplementation is worth discussing with your provider in the following situations: if you have a history of miscarriage (even a single loss), if your luteal phase is consistently shorter than 10 days, if mid-luteal progesterone levels have been measured and found to be below 10 ng/mL, or if you are using frozen donor sperm (as some evidence suggests that the thawing process may produce a slightly different hormonal environment than fresh sperm).
Progesterone can be supplemented via vaginal suppositories, oral capsules (Prometrium), or intramuscular injection. Vaginal suppositories are the most commonly used form for luteal phase support and are available by prescription. The typical protocol is to begin supplementation two to three days after confirmed ovulation (or after insemination) and continue through 10–12 weeks of pregnancy if conception occurs. Some providers recommend beginning supplementation on the day of insemination.
Important: do not begin progesterone supplementation without medical guidance. Progesterone taken before ovulation can actually suppress ovulation and prevent conception. Timing matters, and your provider can help you establish the right protocol for your situation.
The Emotional Weight of Trying Again
The decision to try again after a miscarriage is not purely medical. It is one of the most emotionally complex decisions in the fertility journey, and it deserves to be treated with the gravity it carries.
Grief after miscarriage is not linear, and it does not follow a predictable timeline. You may feel ready to try again within weeks, or you may need months. Both responses are normal. What is not helpful — though it is unfortunately common — is pressure from well-meaning people who either urge you to try again immediately (“the best cure for a miscarriage is another pregnancy”) or caution you to wait longer than medically necessary (“your body needs time to heal”). The right time to try again is when you feel ready, informed by medical guidance but not dictated by other people’s comfort levels.
Many people who try again after a loss describe a paradox: they desperately want to be pregnant again, but the prospect of another pregnancy fills them with anxiety rather than joy. The innocence of the first pregnancy — the uncomplicated excitement of a positive test — has been replaced by hypervigilance. Every cramp, every spot of blood, every moment of nausea that fades triggers fear. This is a normal response to loss, and it does not mean you are not ready to try again. It means you are trying again with more knowledge of what can go wrong, and that knowledge changes the emotional landscape.
Strategies that ICI community members report finding helpful include: setting a specific “worry window” of 15 minutes per day rather than allowing anxiety to pervade every waking hour; avoiding early pregnancy forums during the first trimester; requesting early and frequent monitoring from your provider (many will offer serial hCG draws and an early ultrasound at 6–7 weeks for patients with a history of loss); and working with a therapist who specializes in reproductive loss. The organization Tommy’s provides free resources specifically designed for people navigating pregnancy after loss.
For a deeper exploration of emotional resilience during TTC, our emotional guide to the fertility journey addresses the psychological dimensions of trying to conceive, including grief, anxiety, and the impact on identity and relationships.
Partner Communication After Loss
If you are going through this with a partner, the miscarriage affects both of you — but it may affect you differently, and those differences can create friction precisely when you most need to be a team. Research consistently shows that the gestational partner tends to experience the loss more intensely and for longer, while the non-gestational partner often shifts into a problem-solving or caretaking mode that can feel emotionally distant.
Neither response is wrong, but they can collide painfully. The gestational partner may interpret problem-solving as a lack of grief. The non-gestational partner may feel shut out if their grief is not acknowledged because they were not physically carrying the pregnancy. For same-sex couples using ICI, the dynamics may be further complicated by questions about whether to switch who carries, feelings of guilt from the partner who provided eggs or carried, and the unique visibility of loss in queer family-building.
Concrete strategies for partner communication after loss include: scheduling a specific conversation about readiness to try again rather than letting it come up spontaneously during emotional moments; explicitly discussing how each partner’s grief manifests differently; agreeing on how much to share with family and friends; and establishing a signal for when one partner needs space versus connection. Some couples find that writing letters to each other about their experience of the loss creates a depth of communication that spoken conversation does not easily reach.
If you are a solo parent by choice navigating this alone, building a support network is especially important. Our ICI failure analysis guide includes resources for connecting with others who understand the particular isolation of solo TTC after loss.
When to Escalate from ICI
A miscarriage after ICI does not mean ICI has failed. It means a pregnancy that began was not viable, which is a fundamentally different situation from failure to conceive. The distinction matters because it changes the decision framework for next steps.
If you conceived through ICI, your insemination technique and timing were good enough to achieve pregnancy. That is important information. It means the sperm reached the egg, fertilization occurred, and implantation began. The loss was almost certainly due to factors that ICI cannot control — most commonly, a random chromosomal error in the embryo.
However, there are situations where escalating from at-home ICI to clinic-based care is appropriate after a loss:
Recurrent loss (two or more miscarriages): Warrants a full RPL workup and consideration of clinic-based IUI or IVF with preimplantation genetic testing (PGT-A), which screens embryos for chromosomal abnormalities before transfer. PGT-A can significantly reduce miscarriage rates in couples where chromosomal factors are contributing to recurrent loss.
Age over 38: The rate of chromosomally abnormal embryos increases with age, which means both the miscarriage rate and the time to achieve a viable pregnancy increase. For women over 38 who have experienced a loss, the time efficiency of clinic-based treatment with monitoring may outweigh the convenience and cost advantages of home ICI.
Identified anatomical or hormonal factors: If a workup reveals a uterine septum, significant fibroids, antiphospholipid syndrome, or other treatable conditions, clinic-based management ensures that treatment is optimized and monitored. You may return to home ICI after the condition is addressed, or you may choose to continue with clinic support.
Emotional need for more support: If the prospect of trying at home without medical monitoring creates more anxiety than you can manage, that is a legitimate reason to move to a clinic setting. Having an RE who knows your history, who can offer early monitoring, and who is available to answer questions during the two-week wait is a form of emotional support that has real value.
For many people, the right path after a single miscarriage is to continue with home ICI while adding targeted medical support — a progesterone prescription, a thyroid panel, an early monitoring plan. This hybrid approach preserves the accessibility and privacy of home insemination while incorporating the medical safety net that feels appropriate after a loss. Our two-week wait survival guide offers practical strategies for managing the anxiety of post-insemination waiting, which is particularly intense after a prior loss.